Effects of resistant maltodextrin on bowel movements: a systematic review and meta-analysis by Watanabe N, Suzuki M, Yamaguchi Y, Egashira Y

Get full text

Imputing response rates from means and standard deviations in meta-analyses. by Furukawa, T, Cipriani, A, Barbui, C, Brambilla, P, Watanabe, N

Imputing missing standard deviations in meta-analyses can provide accurate results. by Furukawa, T, Barbui, C, Cipriani, A, Brambilla, P, Watanabe, N

Mirtazapine versus other antidepressive agents for depression. by Watanabe, N, Omori, I, Nakagawa, A, Cipriani, A, Barbui, C, Churchill, R, Furukawa, T

Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation by Kanaji N, Mizoguchi H, Inoue T, Tadokoro A, Watanabe N, Ishii T, Tojo Y, Yamaguchi M, Kadowaki N

Get full text

Milnacipran versus other antidepressive agents for depression. by Nakagawa, A, Watanabe, N, Omori, I, Barbui, C, Cipriani, A, McGuire, H, Churchill, R, Furukawa, T

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. by Watanabe, N, Omori, I, Nakagawa, A, Cipriani, A, Barbui, C, McGuire, H, Churchill, R, Furukawa, T

Fluvoxamine versus other anti-depressive agents for depression. by Omori, I, Watanabe, N, Nakagawa, A, Cipriani, A, Barbui, C, McGuire, H, Churchill, R, Furukawa, T

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis. by Nakagawa, A, Watanabe, N, Omori, I, Barbui, C, Cipriani, A, McGuire, H, Churchill, R, Furukawa, T

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment... by Watanabe, N, Omori, I, Nakagawa, A, Cipriani, A, Barbui, C, McGuire, H, Churchill, R, Furukawa, T

Citalopram versus other anti-depressive agents for depression. by Cipriani, A, Purgato, M, Furukawa, T, Trespidi, C, Imperadore, G, Signoretti, A, Churchill, R, Watanabe, N, Barbui, C

Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis. by Omori, I, Watanabe, N, Nakagawa, A, Akechi, T, Cipriani, A, Barbui, C, McGuire, H, Churchill, R, Furukawa, T

Higher susceptibility of NOD/LtSz-scid Il2rg-/- NSG mice to xenotransplanted lung cancer cell lines by Kanaji N, Tadokoro A, Susaki K, Yokokura S, Ohmichi K, Haba R, Watanabe N, Bandoh S, Ishii T, Dobashi H, Matsunaga T

Get full text

Effects on caregiver burden of a donepezil hydrochloride dosage increase to 10 mg/day in patients with Alzheimer’s disease by Nakamura K, Watanabe N, Ohkawa H, Ando M, Ogura Y, Funabiki S, Kume A, Urano K, Osada T, Yamamura K

Get full text

Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal? by Barbui, C, Cipriani, A, Furukawa, T, Salanti, G, Higgins, J, Churchill, R, Watanabe, N, Nakagawa, A, Omori, I, Geddes, J

Paroxetine versus other anti-depressive agents for depression by Purgato, M, Papola, D, Gastaldon, C, Trespidi, C, Magni, L, Rizzo, C, Furukawa, T, Watanabe, N, Cipriani, A, Barbui, C

Hammerhead ribozyme specifically inhibits vascular endothelial growth factor gene expression in a human hepatocellular carcinoma cell line. by Morino, F, Tokunaga, T, Tsuchida, T, Handa, A, Nagata, J, Tomii, Y, Kijima, H, Yamazaki, H, Watanabe, N, Matsuzaki, S, Ueyama, Y, Nakamura, M

Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1 by Endo M, Odaira K, Ono R, Kurauchi G, Koseki A, Goto M, Sato Y, Kon S, Watanabe N, Sugawara N, Takada H, Kimura E

Get full text

Comparative efficacy and acceptability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis by De Crescenzo, F, Foti, F, Ciabattini, M, Del Giovane, C, Watanabe, N, Sañé Schepisi, M, Quested, D, Cipriani, A, Barbui, C, Amato, L

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. by Cipriani, A, Furukawa, T, Salanti, G, Geddes, J, Higgins, J, Churchill, R, Watanabe, N, Nakagawa, A, Omori, I, McGuire, H, Tansella, M, Barbui, C